Trial comparing treatments for Dry Eye Disease
Official title Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
ClinicalTrials.gov ID: NCT05865379
What this study is testing
- What it's testing
- The goal of this interventional investigation is to compare BUFY01 with SVS20 in the treatment of patients with dry eye disease. The main questions it aims to answer are: Is BUFY01 non-inferior to SVS20 in terms of signs of DED?
- Time commitment: about 3 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- includes:
- At least a 3-month documented history of bilateral dry eye syndrome needing artificial tears;
- At least one eye with Oxford score ≥ 4 and ≤ 9;
- At least one objective sign of tear deficiency (in at least one eligible eye);
- Having a health insurance.
You likely can't join if
- includes:
- Wear of contact lenses starting within the last 2 months;
- Best-corrected visual acuity (BCVA) \> 1.00;
- Severe DED with one of the listed conditions:
- Severe blepharitis;
- Seasonal allergy;
See the full eligibility criteria
- includes:
- At least a 3-month documented history of bilateral dry eye syndrome needing artificial tears;
- At least one eye with Oxford score ≥ 4 and ≤ 9;
- At least one objective sign of tear deficiency (in at least one eligible eye);
- Having a health insurance.
- includes:
- Wear of contact lenses starting within the last 2 months;
- Best-corrected visual acuity (BCVA) \> 1.00;
- Severe DED with one of the listed conditions:
- Severe blepharitis;
- Seasonal allergy;
- Any issues of the ocular surface not related to DED;
- History of ocular trauma, infection or inflammation not related to DED;
- History of ocular surgery, including laser surgery;
- Unstable glaucoma;
- Use of artificial tears with preservative within the last 2 weeks;
- Systemic (enteral or parenteral) or local (topical) use of one of the listed medications:
- Known hypersensitivity to any constituent of the study treatments;
- Pregnancy or breastfeeding;
- Participation in another clinical study within the last 90 days;
- Legally restricted autonomy, freedom of decision and action.
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
- Saint-Priest-en-Jarez, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France; Saint-Priest-en-Jarez, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.